You're reading the free version. Trader adds the live tape and alerts.
Start tracking
STOK Sale Disclosure
Allan Jonathan · SEC Form 4 · Filed Aug 18, 2026
Sale
Calculated transaction value
$4.71K
Allan Jonathan General Counsel & Corp Sec
STOK
Stoke Therapeutics
STOK
Transaction date
Aug 18, 2026
Public filing date
Aug 18, 2026
Filing lag
Filed same day
STOK daily price context
Close on/before transaction
$32.14
Aug 18, 2026
First close after public filing
$33.03
Aug 19, 2026
30-day return after filing
-12.41%
Through Sep 17, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 145 shares @ $32.47
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001966716-26-000012
Filing cohort
Transactions in this filing
Showing 4 of 4
Trades
4
Issuers
1
Estimated value
$91.64K
Buys / sales
0 / 2
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Stoke Therapeutics, Inc. STOK Current | Sale | Aug 18, 2026 | $4.71K |
| Stoke Therapeutics, Inc. STOK | Sale | Aug 18, 2026 | $86.93K |
| Stoke Therapeutics, Inc. STOK | Exercise | Aug 14, 2026 | $0 |
| Stoke Therapeutics, Inc. STOK | Exercise | Aug 14, 2026 | $0 |